Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parakkal Deepak

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2022
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or UstekinumabAndres J Yarur, Dermot McGovern, Maria T Abreu, et al.
Digestive Diseases and Sciences|November 11, 2025
Fistula Outcomes After Seton Removal in Patients with Perianal Fistulizing Crohn's Disease: A Systematic Review and Meta-AnalysisEdgard Medawar, Kevin Chin Koon Siw, Amine Zoughlami, et al.
Crohn'S & Colitis 360|August 4, 2020
Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United StatesEdward L Barnes, Laura Raffals, Millie D Long, et al.
Inflammatory Bowel Diseases|August 22, 2025
Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel DiseasesScott R Anderson, Ali Osman, Mohammad Zamani, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|February 12, 2026
MRI of Perianal Fistulas: Anatomy, Diagnosis, and Perianal Crohn Disease Treatment MonitoringM Hunter Lanier, Mark J Hoegger, Malak Itani, et al.
Gastroenterology|July 27, 2023
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation StudyAndres J Yarur, Alexandra Bruss, Andrea Moosreiner, et al.
The American Journal of Gastroenterology|November 17, 2023
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the PouchMaia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, et al.
The American Journal of Gastroenterology|May 19, 2023
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve RemissionAndres J Yarur, Maria T Abreu, Parakkal Deepak, et al.
The American Journal of Gastroenterology|May 12, 2016
Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's DiseaseParakkal Deepak, Joel G Fletcher, Jeff L Fidler, et al.
Inflammatory Bowel Diseases|October 9, 2018
Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter CohortKimberly N Weaver, Martin Gregory, Gaurav Syal, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2022
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or UstekinumabAndres J Yarur, Dermot McGovern, Maria T Abreu, et al.
Digestive Diseases and Sciences|November 11, 2025
Fistula Outcomes After Seton Removal in Patients with Perianal Fistulizing Crohn's Disease: A Systematic Review and Meta-AnalysisEdgard Medawar, Kevin Chin Koon Siw, Amine Zoughlami, et al.
Crohn'S & Colitis 360|August 4, 2020
Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United StatesEdward L Barnes, Laura Raffals, Millie D Long, et al.
Inflammatory Bowel Diseases|August 22, 2025
Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel DiseasesScott R Anderson, Ali Osman, Mohammad Zamani, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|February 12, 2026
MRI of Perianal Fistulas: Anatomy, Diagnosis, and Perianal Crohn Disease Treatment MonitoringM Hunter Lanier, Mark J Hoegger, Malak Itani, et al.
Gastroenterology|July 27, 2023
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation StudyAndres J Yarur, Alexandra Bruss, Andrea Moosreiner, et al.
The American Journal of Gastroenterology|November 17, 2023
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the PouchMaia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, et al.
The American Journal of Gastroenterology|May 19, 2023
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve RemissionAndres J Yarur, Maria T Abreu, Parakkal Deepak, et al.
The American Journal of Gastroenterology|May 12, 2016
Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's DiseaseParakkal Deepak, Joel G Fletcher, Jeff L Fidler, et al.
Inflammatory Bowel Diseases|October 9, 2018
Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter CohortKimberly N Weaver, Martin Gregory, Gaurav Syal, et al.
Pageof 18